Krishna J. Fisher

Biochemistry, Genetics and Molecular Biology · Life Sciences

28h-index4.8kcitations50works5.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Virus-based gene therapy research(34), Viral Infectious Diseases and Gene Expression in Insects(12), CRISPR and Genetic Engineering(8), Viral gastroenteritis research and epidemiology(8), CAR-T cell therapy research(8)

Publications50 total

Polo-like kinase inhibitors increase AAV production by halting cell cycle progression
Molecular Therapy — Methods & Clinical Development·2025· 3 citedOpen Access
Transcriptomics-informed pharmacology identifies epigenetic and cell cycle regulators that enhance AAV production
Molecular Therapy — Methods & Clinical Development·2024· 7 citedOpen Access
Spliceosome-Mediated Pre-mRNA trans-Splicing Can Repair CEP290 mRNA
Molecular Therapy — Nucleic Acids·2018· 28 citedOpen Access
Enadenotucirev is a well-tolerated group B oncolytic adenovirus that can access and infect tumour cells in cancer patients following intravenous delivery
Human Gene Therapy·2015
Enzyme mediated enhancement of adenovirus spread in cancer cells
Human Gene Therapy·2014
Evaluation of Enadenotucirev (ColoAd1), an oncolytic Ad11/Ad3 chimeric group B adenovirus, in combination with chemotherapeutic agents in a murine model of ovarian cancer
Human Gene Therapy·2014· 1 cited
ColoAd1 a group B oncolytic adenovirus: pre-clinical characterisation and development of 'armed' variants
Human Gene Therapy·2013
Preclinical and early clinical development of an encolytic group B adenovirus, ColoAd1
Human Gene Therapy·2013
Characterisation of a novel group B oncolytic adenovirus, ColoAd1
Oxford University Research Archive (ORA) (University of Oxford)·2011Open Access
Adenovirus type 5 (Ad5) is sequestered and inactivated by binding to coxsackievirus and adenovirus receptor (CAR) and complement receptor 1 (CR1) on human erythrocytes
Oxford University Research Archive (ORA) (University of Oxford)·2008
Development of a 'Stealth' adenovirus vaccine vector
Human Gene Therapy·2008
The effect of polymer coating and different adenovirus serotypes on the innate immune responses to intraperitoneal adenovirus
Oxford University Research Archive (ORA) (University of Oxford)·2008
DNA damage responses after exposure to DNA‐based products
The Journal of Gene Medicine·2005· 13 cited
A Preliminary Evaluation of Recombinant Adeno-Associated Virus Biodistribution in Rhesus Monkeys After Intrahepatic Inoculation <i>In Utero</i>
Human Gene Therapy·2002· 26 cited
Titration of non‐replicating adenovirus as a vector for transducing active TGF‐β<sub>1</sub> gene expression causing inflammation and fibrogenesis in the lungs of C57BL/6 mice
International Journal of Experimental Pathology·2002· 39 citedOpen Access
Spontaneous Mobilization of Integrated Recombinant Adenoassociated Virus in a Cell Culture Model of Virus Latency
Virology·2002· 4 cited
The development of targeted viral and synthetic vectors for gene delivery.
OpenGrey (Institut de l'Information Scientifique et Technique)·2002
Long-Term Protection of Retinal Structure but Not Function Using RAAV.CNTF in Animal Models of Retinitis Pigmentosa
Molecular Therapy·2001· 216 citedOpen Access
AAV-Mediated Delivery of Ciliary Neurotrophic Factor Prolongs Photoreceptor Survival in the Rhodopsin Knockout Mouse
Molecular Therapy·2001· 167 citedOpen Access
Induction of Circular Episomes during Rescue and Replication of Adeno-Associated Virus in Experimental Models of Virus Latency
Virology·2000· 22 cited
page 1 of 3Next →

Frequent Co-authors

Nathan N. Aronson(11), James M. Wilson(10), Lorita Dudus(9), L W Seymour(8), Sam Illingworth(5), Katherine A. High(4), John F. Burda(4), Dongsheng Duan(4), John F. Engelhardt(4), Jean Bennett(4), John Beadle(4), Steven E. Raper(3), Ronald P. DeMatteo(3), Prerna Sharma(3), Jusan Yang(3), Yongping Yue(3), Roland W. Herzog(3), J. Nathan Hagstrom(3), Shing Jen Tai(3), Albert M. Maguire(3)